Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Genital Neoplasms, Male × Radiation Dose Hypofractionation × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 8 Prostatic Neoplasms 6 Sarcoma 4 Carcinoma, Non-Small-Cell Lung 4 Pancreatic Neoplasms 3 Lung Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Intraductal, Noninfiltrating 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma, Ewing 1 Prostate Adenocarcinoma 1 Pituitary Neoplasms 1 Neurilemmoma 1 Nerve Sheath Neoplasms 1 Neoplasms, Radiation-Induced 1 Meningioma 1 Lymphedema 1 Lymphatic Metastasis 1 Locally Recurrent Rectal Cancer 1 Head and Neck Neoplasms 1 Glioblastoma 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Breast Carcinoma In Situ 1 Brain Neoplasms 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

olaparib 1 gallium 68 PSMA-11 1 Pluvicto 1 Abiraterone Acetate 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡